Review Article

Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance

Table 5

Associations between miRNAs and cytokines in relation to cardiovascular diseases and insulin resistance.

miRNARelated cytokinesEffectDescription

miR-34a
miR-21
miR-146
Proinflammatory cytokines (Interleukin, IL, and Tumor Necrosis Factor, TNF)Upregulated miRNA levels with the increase in cytokine levelsMIN6 cells induced with proinflammatory cytokines show a significant induction of miR-34a, miR-21, and miR-146 miRNAs and subsequent blockade of these miRNAs prevented cytokine induced reduction in GSIS and protected β-cells from cytokine induced cell death [25].

miR-103
miR-143
miR-107
TNF-α
(affects insulin and glucose metabolism, provokes insulin resistance, and stimulates lipolysis [26])
Downregulated miRNA levels with the increase in cytokine levelsmiR-103, miR-143, and miR-107 are induced in the process of adipogenesis, but after treatment of TNF-α their levels have shown to be reduced [25, 27].

miR-99a
miR-325
IL-6
(plays a controversial role in the development of insulin resistance and affects glucose metabolism [26])
Downregulated miRNA levels with the increase in cytokine levelsmiR-99a and miR-325 show a negative correlation with IL-6 concentration in human subcutaneous and omental adipose tissue [27].

miRNA-125a-5pIL-6
TNF-α
IL-2
Downregulated cytokine levels with the increase in miRNA-125a-5pmiRNA-125a-5p mediates lipid uptake and decreases the secretion of inflammatory cytokines such as IL-6, TNF-α, and IL-2 [28].

miR-221
miR-222
TNF-αUpregulated miRNA levels with the increase in cytokine levelsmiR-221 and miR-222 correlate positively with TNF and negatively with adiponectin [29].